Filed: 10/16/2026ACC: 0001757283-26-000022
📋 What this filing means
ANDERA PARTNERS filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $175.70M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$175.70M
Total AUM (reported)
11.04M
Total Shares
Allocation by class
SHS$77.91M44.3%
COM$40.00M22.8%
COM SHS$27.29M15.5%
SPONSORED ADS$17.08M9.7%
ADS$13.41M7.6%
Portfolio Concentration
Top 3$143.69M81.8%
4–10$32.01M18.2%
Top 3 weight
81.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 11.04M
Sole
Full voting authority
11.04M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:
KESTRA MED TECHNOLOGIES LTD
SOLEShares2.73M
TypeSH
Market value$77.19M
43.94%
Sole
2.73M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares1.59M
TypeSH
Market value$40.00M
22.77%
Sole
1.59M
Shared
0.00
None
0.00
AVALYN PHARMACEUTICALS INC
SOLEShares929.82K
TypeSH
Market value$26.49M
15.08%
Sole
929.82K
Shared
0.00
None
0.00
AGOMAB THERAPEUTICS NV
SOLEShares1.54M
TypeSH
Market value$17.08M
9.72%
Sole
1.54M
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares3.63M
TypeSH
Market value$13.41M
7.63%
Sole
3.63M
Shared
0.00
None
0.00
EVOMMUNE INC
SOLEShares97.36K
TypeSH
Market value$804.2K
0.46%
Sole
97.36K
Shared
0.00
None
0.00
NYXOAH S A
SOLEShares522.06K
TypeSH
Market value$720.4K
0.41%
Sole
522.06K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KESTRA MED TECHNOLOGIES LTDSOLE | SHS | 2.73M | SH | $77.19M 43.94% | 2.73M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 1.59M | SH | $40.00M 22.77% | 1.59M | 0.00 | 0.00 |
AVALYN PHARMACEUTICALS INCSOLE | COM SHS | 929.82K | SH | $26.49M 15.08% | 929.82K | 0.00 | 0.00 |
AGOMAB THERAPEUTICS NVSOLE | SPONSORED ADS | 1.54M | SH | $17.08M 9.72% | 1.54M | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 3.63M | SH | $13.41M 7.63% | 3.63M | 0.00 | 0.00 |
EVOMMUNE INCSOLE | COM SHS | 97.36K | SH | $804.2K 0.46% | 97.36K | 0.00 | 0.00 |
NYXOAH S ASOLE | SHS | 522.06K | SH | $720.4K 0.41% | 522.06K | 0.00 | 0.00 |